Pharmaceutical composition for oral administration
An oral pharmaceutical composition characterized in that it consists of a suspension of a platinum complex of general formula I, wherein A and A' independently of one another are an NH3 group or an amino or diamino group containing 1 to 18 carbon atoms, B and B' independently of one anothe...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
12.08.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | An oral pharmaceutical composition characterized in that it consists of a suspension of a platinum complex of general formula I, wherein A and A' independently of one another are an NH3 group or an amino or diamino group containing 1 to 18 carbon atoms, B and B' independently of one another are a halogen atom or a hydroxy group or are an -0-C(O)-R or an -0-C(O)-R' group wherein R and R' independently of one another are hydrogen atom, an alkyl, alkenyl, aryl, aralkyl, alkylamino or alkoxy group which groups contain 1 to 10 carbon atoms, or functional derivatives of these groups, X and X' independently of one another are a halogen atom or a monocarboxylate group containing 1 to 20 carbon atoms, or X and X' together form a dicarboxylate group containing 2 to 20 carbon atoms, in at least one pharmaceutically acceptable vegetable, animal, mineral, synthetic or semisynthetic oil and/or in at least one pharmaceutically acceptable vegetable, animal, mineral, synthetic or semisynthetic oily substance, in which suspens |
---|---|
Bibliography: | Application Number: CN200780030866 |